new stage, new concept, new pattern. The 14th Health China Forum , co-sponsored by People's Daily Health Client and Health Times , had a grand opening on July 28 at the People's Daily Health Client Studio in the People's Daily New Media Building. The conference will set up a main forum and 15 parallel forums. Leaders from the People's Daily, National Health Commission, National Medical Insurance Administration and other relevant departments, academicians of the two academies, authoritative experts, and well-known scholars will focus on the "14th Five-Year Plan" Healthy China Action and Hot issues in the development of medicine and health were discussed.
On August 29, 2022, from 15:30 to 17:00, the 14th Healthy China Forum·China Power Parallel Forum on Men's Health was held, and the People's Daily Health Client was broadcast live online simultaneously.
In January this year, the world's first innovative anti-ED drug developed based on the physiological characteristics of Chinese men was launched. It not only broke the long-term monopoly of European and American companies in the field of anti-ED drugs, but was also a huge progress in China's independent innovative drugs. In the future, when carrying out international academic cooperation and promoting high-quality domestic anti-ED drugs to go global, how should we make the voice of Chinese pharmaceutical companies louder and demonstrate the strength of China's original research? At the forum, seven experts will share together.
This forum specially invited Jiang Hui, secretary of the Party Committee of Peking University First Hospital, president of the Chinese Sexology Society, Zhen Hongli, PhD in sexual psychology from Peking University Medical School, author of the best-selling book "Talking about Sex and Love", and Yue Chairman of Kang Pharmaceutical Group Yu Weishi , Director of Yuekang Pharmaceutical Group, Assistant to the Chairman Yu Pengfei, Chairman of Deshengtang Group , Longyan , founder of 111 Medical Center, Zhou Feng, co-founder and chief strategy officer of Ark Jianke, Song Gengshen, director of the Drug Research Institute of Yuekang Pharmaceutical Group, and other association leaders, experts, scholars, and industry elites from the field of sexual medicine will Focusing on the current status of men's health and psychology in China, the development prospects of the men's health service industry, and the development of China's first original anti-ED innovative drug, we will jointly discuss how to build sustainable innovation in the research and development of men's health drugs in China and support the Healthy China Initiative. Come and ask questions!
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-